Literature DB >> 8787841

Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia.

C R Harrington1, M Roth, J H Xuereb, P J McKenna, C M Wischik.   

Abstract

Apolipoprotein E type epsilon 4 alleles are increased in both Alzheimer's disease (AD) and cortical Lewy body dementia, while the epsilon 2 allele has been associated as a protective factor against the development of dementia in AD. We have determined APOE genotype in schizophrenic patients coming to autopsy (age range 19-95 years). The allele frequencies in this group were: epsilon 2, 6.0%; epsilon 3, 67.9%; and epsilon 4, 26.2%. Three patients (14%) were homozygous for the epsilon 4 allele. Thus, schizophrenia is associated with an increased epsilon 4 allele frequency, as compared with controls (P = 0.01), that was indistinguishable from that found in either AD or Lewy body dementia. The increased epsilon 4 allele frequency was not associated with increased age of schizophrenia patient, indicating that it was not due to the co-existence of AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787841     DOI: 10.1016/0304-3940(95)12218-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 2.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.

Authors:  Fidel Vila-Rodriguez; William G Honer; Sheila M Innis; Cheryl L Wellington; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

4.  Apolipoprotein E polymorphisms and primary glaucoma in Saudis.

Authors:  Najwa Mohammed Al-Dabbagh; Nourah Al-Dohayan; Misbahul Arfin; Mohammad Tariq
Journal:  Mol Vis       Date:  2009-05-04       Impact factor: 2.367

5.  Apolipoprotein E polymorphism is associated with age of onset in schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Kari M Mattila; Riikka Rontu; Esa Leinonen; Terho Lehtimäki
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

Review 6.  Developmental vitamin D deficiency and schizophrenia: the role of animal models.

Authors:  S A Schoenrock; L M Tarantino
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

7.  Apolipoprotein E polymorphism in patients with neuropsychiatric SLE.

Authors:  Rudolf Pullmann; Mária Skerenová; Jana Hybenová; Jozef Lukác; Jozef Rovenský; Rudolf Pullmann
Journal:  Clin Rheumatol       Date:  2004-01-29       Impact factor: 2.980

8.  APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients.

Authors:  Wei Li; Fengju Liu; Rui Liu; Xinmei Zhou; Guanjun Li; Shifu Xiao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

9.  Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia.

Authors:  Andrew Stuart Gibbons; Elizabeth A Thomas; Elizabeth Scarr; Brian Dean
Journal:  Front Psychiatry       Date:  2010-07-08       Impact factor: 4.157

10.  Developmental regulation of expression of schizophrenia susceptibility genes in the primate hippocampal formation.

Authors:  G Favre; P Banta Lavenex; P Lavenex
Journal:  Transl Psychiatry       Date:  2012-10-23       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.